HSDT Helius Medical Technologies, Inc. Stock Quote

HSDT [NASD]

Index	-	P/E	-	EPS (ttm)	-7.05	Insider Own	1.10%	Shs Outstand	3.78M	Perf Week	6.12%
Market Cap	2.04M	Forward P/E	-	EPS next Y	-2.25	Insider Trans	0.00%	Shs Float	3.36M	Perf Month	-50.07%
Income	-19.10M	PEG	-	EPS next Q	-1.12	Inst Own	28.30%	Short Float	5.16%	Perf Quarter	-66.61%
Sales	0.60M	P/S	3.40	EPS this Y	70.50%	Inst Trans	16.99%	Short Ratio	0.06	Perf Half Y	-86.85%
Book/sh	3.59	P/B	0.15	EPS next Y	46.20%	ROA	-139.90%	Target Price	25.00	Perf Year	-96.44%
Cash/sh	2.88	P/C	0.19	EPS next 5Y	-	ROE	-181.20%	52W Range	0.45 - 15.68	Perf YTD	-89.71%
Dividend	-	P/FCF	-	EPS past 5Y	15.50%	ROI	-615.30%	52W High	-96.59%	Beta	0.71
Dividend %	-	Quick Ratio	4.60	Sales past 5Y	-	Gross Margin	35.40%	52W Low	18.47%	ATR	0.25
Employees	19	Current Ratio	4.70	Sales Q/Q	50.00%	Oper. Margin	-	RSI (14)	39.51	Volatility	11.21% 18.23%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	26.00%	Profit Margin	-	Rel Volume	2.43	Prev Close	0.55
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 15 AMC	Payout	-	Avg Volume	2.89M	Price	0.53
Recom	1.00	SMA20	-38.46%	SMA50	-57.67%	SMA200	-86.32%	Volume	7,028,452	Change	-2.85%

Mar-24-21

Initiated

Noble Capital Markets

Outperform

$20

Aug-15-22 04:05PM	Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results GlobeNewswire
Aug-10-22 07:05AM	Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022 GlobeNewswire
Aug-05-22 08:38AM	Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering GlobeNewswire -53.12%
Jul-15-22 10:55AM	Lab Notes: CHOP develops ADHD diagnostic tool, GSK unveils flu vaccine plans, Helius launches training program American City Business Journals -5.31%
Jul-12-22 07:05AM	Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy GlobeNewswire
Jun-17-22 12:00PM	Helius Medical Technologies, Inc. (HSDT) Upgraded to Buy: Here's Why Zacks
Jun-06-22 07:05AM	Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting GlobeNewswire
Jun-01-22 07:05AM	Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS® GlobeNewswire +35.62%
May-31-22 08:36AM	Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference GlobeNewswire +8.96%
May-24-22 04:05PM	Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire -8.57%
May-17-22 07:30AM	Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program GlobeNewswire
May-12-22 06:50AM	Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS® GlobeNewswire -23.71%
May-03-22 07:05AM	Helius Medical Technologies, Inc. to Release First Quarter 2022 Financial Results on May 12, 2022 GlobeNewswire
Apr-27-22 07:05AM	Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS® GlobeNewswire
Apr-26-22 07:05AM	Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking Ability GlobeNewswire
Mar-14-22 04:05PM	Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results GlobeNewswire
Feb-17-22 05:20PM	Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire -6.41%
Jan-26-22 04:30PM	Helius Medical Technologies, Inc. Provides Corporate Update GlobeNewswire
Dec-20-21 05:00PM	Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Dec-17-21 07:05AM	Helius Medical Technologies, Inc. Partners with the Medical University of South Carolina in Pilot Trial on Stroke GlobeNewswire
Dec-14-21 07:05AM	Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS® GlobeNewswire
Dec-06-21 07:05AM	Helius Medical Technologies, Inc.s Dr. Antonella Favit-Van Pelt to Present at 4th International Brain Stimulation Conference on December 9 GlobeNewswire
Nov-15-21 11:49AM	CEO Of Helius Medical Tech Makes $300K Buy Benzinga
06:50AM	Helius Medical Technologies, Inc. to Participate in 1x1 Meetings at 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021 GlobeNewswire
Nov-12-21 04:05PM	Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option GlobeNewswire
Nov-10-21 04:05PM	Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial Results GlobeNewswire -29.45%
01:15PM	Helius Medical Technologies, Inc. (HSDT) Reports Q3 Loss, Tops Revenue Estimates Zacks
10:11AM	Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2% Benzinga
08:30AM	Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common Stock GlobeNewswire
Nov-09-21 04:30PM	Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire +5.81%
Nov-08-21 07:05AM	Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial Site GlobeNewswire -7.52%
Nov-04-21 06:55AM	Helius Medical Technologies, Inc. Receives PoNS® Market Authorization in Australia GlobeNewswire
Nov-03-21 03:01PM	Helius Medical Technologies, Inc. (HSDT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Nov-01-21 07:05AM	Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021 GlobeNewswire
Oct-29-21 04:30PM	Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire
Oct-12-21 07:05AM	Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth Conference GlobeNewswire
Sep-22-21 04:05PM	Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference GlobeNewswire
Sep-14-21 07:05AM	Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors GlobeNewswire
Sep-07-21 07:05AM	Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire
Aug-25-21 07:00AM	Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange GlobeNewswire
Aug-18-21 09:28AM	We're Keeping An Eye On Helius Medical Technologies' (NASDAQ:HSDT) Cash Burn Rate Simply Wall St.
Aug-17-21 08:28AM	The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga -10.17%
07:05AM	Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke GlobeNewswire
Aug-12-21 07:15PM	Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:05PM	Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results GlobeNewswire
Aug-11-21 05:00PM	Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
07:05AM	Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians GlobeNewswire
Aug-05-21 03:01PM	Will Helius Medical Technologies, Inc. (HSDT) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-12-21 04:05PM	Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July GlobeNewswire
Jul-08-21 07:30AM	Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer GlobeNewswire
Jul-07-21 05:30PM	Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics GlobeNewswire
Jun-30-21 07:30AM	Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021 GlobeNewswire
Jun-15-21 08:30AM	Helius Medical Technologies, Inc. Expands Executive Leadership Team with the Appointment of Dane C. Andreeff as President and Chief Executive Officer and Jeffrey S. Mathiesen as Chief Financial Officer GlobeNewswire -6.74%
Jun-08-21 04:05PM	Helius Medical Technologies, Inc. to Participate in Noble Capital Markets Virtual Road Show Series GlobeNewswire
Jun-02-21 07:05AM	Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America GlobeNewswire
May-17-21 04:05PM	Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results GlobeNewswire
Apr-19-21 09:00AM	Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021 ACCESSWIRE
Apr-15-21 08:35AM	Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st GlobeNewswire
Apr-07-21 04:30PM	Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021 GlobeNewswire
Mar-29-21 06:30AM	Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS Device GlobeNewswire -7.56%
Mar-17-21 04:05PM	Helius Medical Technologies, Inc. to Present at the Investor Summit Groups Q1 Virtual Summit on March 23rd GlobeNewswire
07:05AM	Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors GlobeNewswire
Mar-10-21 04:05PM	Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire -7.36%
Feb-22-21 12:45AM	Media Advisory - Imagery and video footage of the arrival of the COVID-19 vaccine CNW Group
Feb-02-21 07:30AM	Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021 GlobeNewswire
Feb-01-21 05:15PM	Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option GlobeNewswire
Jan-28-21 08:41AM	IIROC Trade Resumption - HSM CNW Group -10.19%
08:30AM	Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market GlobeNewswire
Jan-20-21 07:05AM	Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices GlobeNewswire
Jan-19-21 07:05AM	Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards GlobeNewswire +7.39%
Jan-15-21 12:37PM	Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference GlobeNewswire
Jan-13-21 07:00AM	Sidoti Virtual Investor Conference ACCESSWIRE
Jan-11-21 07:05AM	Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis GlobeNewswire +7.72%
Jan-05-21 04:05PM	Helius Medical Technologies, Inc. Comments on Unusual Market Activity GlobeNewswire +63.40%
Jan-04-21 07:05AM	Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January GlobeNewswire -14.80%
Dec-31-20 07:05AM	Helius Medical Technologies, Inc. Announces Reverse Stock Split GlobeNewswire -10.12%
Nov-19-20 06:45AM	Sidoti Virtual Microcap Investor Conference ACCESSWIRE
Nov-12-20 04:05PM	Helius Medical Technologies, Inc. Reports Third Quarter of Fiscal Year 2020 Financial Results GlobeNewswire
09:20AM	Helius Medical Technologies to Present at the virtual Fall Investor Summit on November 16th-18th ACCESSWIRE
Nov-05-20 07:05AM	Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November GlobeNewswire
Nov-04-20 07:05AM	Helius Medical Technologies, Inc. Announces the Expansion to a Total of 27 Authorized PoNS Treatment Clinic Locations Across Canada GlobeNewswire
Nov-02-20 05:00PM	Helius Medical Technologies to Release Third Quarter of Fiscal Year 2020 Financial Results on November 12, 2020 GlobeNewswire
Oct-26-20 05:45PM	Helius Medical Technologies Announces Closing of $3.4 Million Private Placement GlobeNewswire -5.30%
Oct-21-20 04:32PM	Helius Medical Technologies Announces $3.4 Million Private Placement GlobeNewswire
Oct-19-20 05:17PM	10 Stocks Moving In Monday's After Hours Session Benzinga +7.59%
04:32PM	Helius Medical Technologies, Inc. Provides Update on FDAs Review of its Request for De Novo Classification and Clearance of the PoNS Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis GlobeNewswire
Oct-14-20 07:05AM	Helius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple Sclerosis Insights GlobeNewswire
Oct-08-20 07:30AM	Helius Medical Technologies, Inc. Announces Formation of Multiple Sclerosis Scientific Advisory Board GlobeNewswire +8.67%
Sep-08-20 07:05AM	Helius Medical Technologies, Inc. Announces Publication of Peer-Reviewed Study: Translingual Neural Stimulation with the Portable Neuromodulation Stimulator (PoNS) Induces Structural Changes Leading to Functional Recovery in Patients with Mild-to-Moderate Traumatic Brain Injury GlobeNewswire +9.90%
Sep-02-20 06:21PM	LD Micro 360 Companies --Set to Present this Week. ACCESSWIRE -11.09%
Aug-31-20 02:00PM	Helius Medical Technologies, Inc. to Present at Three Upcoming Investor Conferences in September GlobeNewswire
Aug-25-20 07:05AM	Helius Medical Technologies, Inc. Announces Departure of President, Chief Executive Officer and Chairman Philippe Deschamps; Board of Directors Appoints Dane C. Andreeff as Interim President and Chief Executive Officer and Appoints Blane Walter as Chairman of the Board of Directors GlobeNewswire
Aug-12-20 06:05PM	Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates Zacks -10.40%
04:05PM	Helius Medical Technologies, Inc. Reports Second Quarter of Fiscal Year 2020 Financial Results GlobeNewswire
Aug-10-20 07:05AM	Helius Medical Technologies to Release Second Quarter of Fiscal Year 2020 Financial Results on August 12, 2020 GlobeNewswire
Aug-06-20 12:30PM	Helius Medical Technologies, Inc. (HSDT) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks -7.23%
07:05AM	Helius Medical Technologies, Inc. Submits Request for FDA Clearance for PoNS Device; Reports Preliminary Financial Results for the Second Quarter and Six Months Ended June 30, 2020 GlobeNewswire
Aug-05-20 03:34PM	LD Micro-Announces Preliminary List of Presenters for the LD 500. ACCESSWIRE
Jul-14-20 07:05AM	Helius Medical Technologies Announces the Dismissal of the Shareholder Class Action Lawsuit GlobeNewswire +10.38%
Jun-15-20 07:00AM	INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Helius Medical Technologies, Inc. for Potential Breach of Fiduciary Duty Claims GlobeNewswire +7.06%

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ANDREEFF DANE	President and CEO	Dec 17	Buy	5.25	5,100	26,789	53,779	Dec 21 08:15 AM
MATHIESEN JEFFREY S	CFO and Treasurer	Dec 17	Buy	5.31	3,000	15,929	3,937	Dec 20 08:15 AM
ANDREEFF DANE	President and CEO	Nov 12	Buy	8.00	37,500	300,000	86,482	Nov 15 08:00 AM
ANDREEFF DANE	President and CEO	Sep 15	Buy	14.72	10,000	147,222	63,522	Sep 16 04:05 PM
ANDREEFF DANE	President and CEO	Sep 10	Buy	14.96	10,000	149,629	58,114	Sep 13 04:05 PM
ANDREEFF DANE	President and CEO	Sep 08	Buy	14.83	6,000	88,957	52,706	Sep 09 04:06 PM
ANDREEFF DANE	President and CEO	Sep 07	Buy	14.86	4,450	66,139	49,461	Sep 09 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience